Skip to main content

Open Ledger

Eli Lilly financials in Beancount

Sector: Healthcare

Eli Lilly keeps 6 recorded periods through FY2026Q2 as a balanced Beancount ledger — inspect the figures below, then open the live books.

Updated

View the live ledger

Latest figures

Revenue
$23B (22,974 MUSD)
Net income
$7.1B (7,095 MUSD)
Net margin
30.9%

Issuer filing (FY2026Q2)

Recorded history

Recorded revenue and net income in MUSD (Annual periods).
PeriodPeriod endRevenueNet income
FY2021December 31, 2021$28.3B (28,318.4 MUSD)$5.6B (5,581.7 MUSD)
FY2022December 31, 2022$28.5B (28,541.4 MUSD)$6.2B (6,244.8 MUSD)
FY2023December 31, 2023$34.1B (34,124.1 MUSD)$5.2B (5,240.4 MUSD)
FY2024December 31, 2024$45B (45,042.7 MUSD)$10.6B (10,590 MUSD)
FY2025December 31, 2025$65.2B (65,179 MUSD)$20.6B (20,640 MUSD)
Recorded revenue and net income in MUSD (Quarter periods).
Recorded revenue and net income in MUSD (Quarter periods).
PeriodPeriod endRevenueNet income
FY2026Q2June 30, 2026$23B (22,974 MUSD)$7.1B (7,095 MUSD)

Coverage

Coverage6
  • FY2021
  • FY2022
  • FY2023
  • FY2024
  • FY2025
  • FY2026Q2

Earnings analyses

More companies in this sector